Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 912 participants.

Also called NCT03463317

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 912 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03463317
Other papers using this trial's data
  • Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation The New England journal of medicine, 2026-04-02 DOI, PubMed 41849741

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03463317. Randomized; no masking; primary purpose prevention. Start 2018-02-28 (actual); primary completion 2024-11-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
Acronym
CLOSURE-AF
Intervention (Device)
CE-mark approved LAA closure devices
Intervention (Drug)
Acetylsalicylic acid
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Dabigatran
Intervention (Drug)
Rivaroxaban
Intervention (Drug)
Apixaban
Intervention (Drug)
Edoxaban
Intervention (Drug)
Phenprocoumon
Intervention (Drug)
Warfarin
Lead sponsor
Charite University, Berlin, Germany (class: other)
Collaborator
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (class: other)
Collaborator
Atrial Fibrillation Network (class: other)
Collaborator
Stiftung Institut fuer Herzinfarktforschung (class: other)

Record details

Record id
cardio:ct-nct03463317
Content hash
14b00ee304e8089ea74a001ded804e8737b250cb688fca853ba9dcd59d5d5366